SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt trades in pink of its health on BSE

07 Nov 2014 Evaluate

Wockhardt is currently trading at Rs. 759.80, up by 7.60 points or 1.01 % from its previous closing of Rs. 752.20 on the BSE.

The scrip opened at Rs. 770.00 and has touched a high and low of Rs. 770.00 and Rs. 748.10 respectively. So far 102348 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 886.50 on 15-Sep-2014 and a 52 week low of Rs. 336.60 on 16-Dec-2013.

Last one week high and low of the scrip stood at Rs. 780.00 and Rs. 736.00 respectively. The current market cap of the company is Rs. 8352.62 crore.

The promoters holding in the company stood at 74.53 % while Institutions and Non-Institutions held 8.27 % and 17.07 % respectively.

Wockhardt Hospitals has opened a 350-bed hospital in South Mumbai at an estimated cost of Rs 300 crore. The tertiary care hospital bundles major specialities including cardiac and critical care.

Two more hospitals are on Wockhardt’s radar in Delhi and another in suburban Mumbai and funds for this would be raised internally. Additionally, the Delhi hospital was expected to take another two years to operationalise.

Wockhardt hospitals is one of the leading tertiary care, super specialty healthcare networks in India offering high quality healthcare services. The chain of hospitals is owned by the parent company Wockhardt, which has featured on the list of Top 10 pharmaceutical companies in India.

 

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×